PUBLICACIÓN

Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy

ACCEDER A LA PUBLICACIÓN: Orcid

Mukul Sharma et al.

2022 International Journal of Stroke

Neurology (clinical) (Q1), Neurology (Q1)

JCR: 6.7

SJR: 1.952


DOI

10.1177/17474930211058012

ISSN

1747-4930

BIBTEX

@article{Sharma_2021, doi = {10.1177/17474930211058012}, url = {https://doi.org/10.1177%2F17474930211058012}, year = 2021, month = {nov}, publisher = {{SAGE} Publications}, volume = {17}, number = {7}, pages = {799--805}, author = {Mukul Sharma and Eric E Smith and Lesly A Pearce and Kanjana S Perera and Scott E Kasner and Byung-Woo Yoon and Sebastian F Ameriso and Josep Puig and Dorte Damgaard and Jochen B Fiebach and Keith W Muir and Roland C Veltkamp and Danilo S Toni and Nikolay Shamalov and Rubens J Gagliardi and Robert Mikulik and Stefan T Engelter and Daniel Bereczki and Martin J O'Donnell and Feryal Saad and Ashkan Shoamanesh and Scott D Berkowitz and Hardi Mundl and Robert G Hart and}, title = {Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: {NAVIGATE} {ESUS} {MRI} substudy}, journal = {International Journal of Stroke}}


AUTORES DE LA UEX